Tg(Krt15-cre/ERT2)12Blpn
Transgene Detail
|
Symbol: |
Tg(Krt15-cre/ERT2)12Blpn |
Name: |
transgene insertion 12, Cedric Blanpain |
MGI ID: |
MGI:5478553 |
Synonyms: |
K15-CREER |
Transgene: |
Tg(Krt15-cre/ERT2)12Blpn Location: unknown
|
Alliance: |
Tg(Krt15-cre/ERT2)12Blpn page
|
|
Strain of Origin: |
Not Specified
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Tg(Krt15-cre/ERT2)12Blpn expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Note |
Not Specified |
Krt15 |
|
|
|
|
Mutation details: The Krt15 promoter fragment was cloned into a plasmid with the cre/ERT2 sequence. The vector was injected into fertilized oocytes. Transgenic founders were produced and crossed to EYTP-reporter mice for analysis of recombination profiles. Founder line 12 which targeted bulge cells more specifically than other lines was established and used for further study.
(J:195334)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Krt15
(species not specified)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:195334 Youssef KK, et al., Identification of the cell lineage at the origin of basal cell carcinoma. Nat Cell Biol. 2010 Mar;12(3):299-305 |
All: |
1 reference(s) |
|